Jens Atzpodien
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology top 5%
- Immunology top 2%
- Cancer Research top 5%
- Co-authors
- Hartmut KirchnerMartina ReitzT WandertJan BuerEnrique Lopez HänninenH. PoliwodaH. KirchnerAnke Franzke
- Topics
- Cancer Immunotherapy and Biomarkers (47 papers)Renal cell carcinoma treatment (35 papers)Immunotherapy and Immune Responses (34 papers)
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Jens Atzpodien
139 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 120
- Oncology 2.2k
- Pulmonary and Respiratory Medicine 1.4k
- Molecular Biology 1.3k
- Immunology 1.2k
- Cancer Research 638
Countries citing papers authored by Jens Atzpodien
This map shows the geographic impact of Jens Atzpodien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Atzpodien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Atzpodien more than expected).
Fields of papers citing papers by Jens Atzpodien
This network shows the impact of papers produced by Jens Atzpodien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Atzpodien. The network helps show where Jens Atzpodien may publish in the future.
Co-authorship network of co-authors of Jens Atzpodien
This figure shows the co-authorship network connecting the top 25 collaborators of Jens Atzpodien. A scholar is included among the top collaborators of Jens Atzpodien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Atzpodien. Jens Atzpodien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 30 | |
| 2 | 33 | |
| 3 | 7 | |
| 4 | 2 | |
| 5 | 8 | |
| 6 | 18 | |
| 7 | 22 | |
| 8 | 8 | |
| 9 | 3 | |
| 10 | 22 | |
| 11 | 5 | |
| 12 | 7 | |
| 13 | 21 | |
| 14 | 4 | |
| 15 | 111 | |
| 16 | 1 | |
| 17 | 9 | |
| 18 | 1 | |
| 19 | 17 | |
| 20 | 8 |
About Jens Atzpodien
Jens Atzpodien is a scholar working on Oncology, Immunology and Hematology, having authored 141 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (47 papers), Renal cell carcinoma treatment (35 papers) and Immunotherapy and Immune Responses (34 papers). The work is most often cited by research in Oncology (2.2k citations), Immunology (1.2k citations) and Cancer Research (638 citations). Jens Atzpodien has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Hartmut Kirchner, Martina Reitz, T Wandert, Jan Buer, Enrique Lopez Hänninen, H. Poliwoda, H. Kirchner, Anke Franzke, Arnold Ganser and Iris Dallmann. Their work appears in journals such as New England Journal of Medicine, The Lancet and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.